All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 167 of 206 pages ‹ First < 165 166 167 168 169 > Last ›
HSL6900
Barents Group LLC
Factors affecting the growth of prescription drug expenditures
Washington, D.C: National Institute for Health Care Management Research and Educational Foundation 1999 Jul 9
HSL20172
Hansen K
S4 advertising in mainstream press
Australian Medicine 1999 July 53
http://ama.com.au/node/3634
HSL5314
Bates DW, Teich JM, Lee J, Seger D, Kuperman GJ, Ma'Luf N, Boyle D, Leape L.
The impact of computerized physician order entry on medication error prevention.
J Am Med Inform Assoc 1999 Jul-Aug 01;6:(4):313-21
http://www.jamia.org/cgi/content/full/6/4/313
HSL1859
Eckardt VF.
[Promoting research and graduate education by the pharmaceutical industry--scientific progress or marketing strategy?]
Z Gastroenterol. 1999 Jul;Suppl 2:19-27
HSL2076
Elstein AS.
Heuristics and biases: selected errors in clinical reasoning.
Acad Med 1999 Jul;74:(7):791-4
HSL6843
Chepesiuk R.
Keeping pharmaceutical advertising on track.
Can Fam Physician 1999 Jul;45:1652-3:
HSL7940
Neuman SL.
Year 2000 in pharmacy: business as usual or disaster in progress?
Journal of Managed Care Pharmacy 1999 Jul-Aug;5:305, 308-310
HSL7961
Wang JC.
Beyond DTC: what to do if FDA scales back DTC advertising
Pharmaceutical Executive 1999 Jul;19:58-60
HSL7970
Sesti LM.
Principles of pharmacy . . . ethics & practice. Part 2
Michigan Pharmacist 1999 Jul-Aug;37:44-45
HSL7976
Smith D.
Risk management: consumer holds the trump card
Pharmaceutical Executive 1999 Jul;19:2
HSL7977
Morris L.
Reminder and help-seeking ads: alive and well
Pharmaceutical Executive 1999 Jul;19:14
HSL7979
West D.
DTC decisions: from revolution to evolution
Pharmaceutical Executive 1999 Jul;19:4-6, 8
HSL7980
Breu J.
Will patent-holder's tactics forestall generic competition?
Drug Topics 1999 Jul;143:
HSL16737
Lurie P, Wolfe SM
Proposed revisions to the Declaration of Helsinki. Paving the way for globalization in research.
Western Journal of Medicine 1999 Jul;171:(1):6
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1305720/?tool=pubmed
HSL237
Warlow C, Sandercock P, Dennis M, Wardlaw J.
Research funding.
Lancet 1999 Jun 26;353:(9171):2250
HSL19801
Matthews JNS
Sponsored trials do not necessarily give more-favourable results
BMJ 1999 Jun 26;318:1762
http://www.bmj.com/content/318/7200/1762.2.full
HSL6861
Koepp R, Miles SH.
Meta-analysis of tacrine for Alzheimer disease: the influence of industry sponsors.
JAMA 1999 Jun 23-30;281:(24):2287-8
http://jama.ama-assn.org/cgi/content/full/281/24/2287
HSL2012
Galewitz P.
Study: Drugmaker Ads Can Backfire
AP Business Writer 1999 Jun 17
HSL6866
Lexchin J.
PMAC code of marketing practices.
CMAJ 1999 Jun 1;160:(11):1556
http://www.cma.ca/cmaj/vol-160/issue-11/letters-11.htm#7
HSL16735
Wolfe S, Sasich L
The Wild, Wild Web
The Washington Post 1999 Jun 1
HSL236
Williams AH, Rowell M.
Private enterprise and public good: ethical issues in the funding of clinical research.
Ann R Coll Physicians Surg Can 1999 Jun;32:(4):227-31
HSL2056
Bell RA, Wilkes MS, Kravitz RL.
Advertisement-induced prescription drug requests: patients' anticipated reactions to a physician who refuses.
J Fam Pract 1999 Jun;48:(6):446-52
HSL6899
Lexchin J.
Re: the promotion of Atrovent (ipratropium bromide)
1999 Jun;
HSL7936
Smith D.
Who says consumers can't make decisions?
Pharmaceutical Executive 1999 Jun;19:19
HSL7937
Prince R.
Generic firms seek government help to fight manufacturers for drug marketing rights
Pharmacy Practice News 1999 Jun;26:1, 16
HSL7938
West D.
Crop at the top: popular ad shops of the DTC world
Pharmaceutical Executive 1999 Jun;19:6-8, 10, 12, 14
HSL7939
Wechsler J.
Risky business
Pharmaceutical Executive 1999 Jun;19:3
HSL8140
Rolland PD, Kablinger AS.
Recruitment for clinical trials: psychopharmacology research clinic's experience in recruiting for depression studies
ASHP Annual Meeting 1999 Jun;56:
HSL8141
Hatwig CA, Ritz P, Nunan R, Ferer M, Dunwoody C.
Designing and implementing a public relations campaign for pharmacists
ASHP Annual Meeting 1999 Jun;56:
HSL6873
Mansour P.
More lessons from unfortunate events in Toronto.
Lancet 1999 May 29;353:(9167):1888
HSL7965
Bremer S.
Let the good times roll
Chemist and Druggist 1999 May 29;251:16, 18, 20
HSL16736
Wolfe S, Lurie P
Comments in correspondence section in response to article entitled 'Science, ethics, and future of research into maternal-infant transmission of HIV-1'
The Lancet 1999 May 29;353:9167
HSL6846
Donohoe MT, Matthews H.
Wasted paper in pharmaceutical samples.
N Engl J Med 1999 May 20;340:(20):1600
HSL20298
Lexchin J
Rethinking the numbers on adverse drug reactions
JAMC 1999 May 18;160:(10):1432
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232593/
HSL6844
Dieppe P, Chard J, Tallon D, Egger M.
Funding clinical research.
Lancet 1999 May 8;353:(9164):1626
HSL14667
Does continuing medical education in general practice make a difference?
Cantillon P, Jones R
BMJ 1999 May 8;318:(7193):1276-9
http://www.bmj.com/cgi/content/full/318/7193/1276
HSL5300
Chan DH, Leclair K, Kaczorowski J.
Problem-based small-group learning via the Internet among community family physicians: a randomized controlled trial.
MD Comput 1999 May-Jun 01;16:(3):54-8
HSL6865
Lexchin J.
How patient outcomes are reported in drug advertisements.
Can Fam Physician 1999 May;45:1213-6:
HSL6896
Dr. Celebrity
Consumer Reports 1999 May8-9
HSL6897
Molloy DW, Smith SD, Jubelis RM.
The Ideal Detail Program - comprehensive, up-to-date drug detailing
Health Law in Canada 1999 May;19:(4):89-95
HSL6898
Paytash CA.
The learned intermediary doctrine and patient package inserts: a balanced approach to preventing drug-related injury.
Stanford Law Rev 1999 May;51:(5):1343-71
HSL7942
West D.
Sensitivity training
Pharmaceutical Executive 1999 May;19:
HSL7955
Smith DL.
Your patient package insert: does it help or hinder?
Pharmaceutical Executive 1999 May;19:
HSL7962
West D.
Remote control? DTC ponders the twilight zone of TV advertising
Pharmaceutical Executive 1999 May;19:
HSL7963
Wechsler J.
Regulating the Internet
Pharmaceutical Executive 1999 May;19:
HSL11580
Lee TH.
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. What constitutes a useful economic study? The health systems perspective.
Am Heart J. 1999 May;137:(5):S67-70
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=10220600
HSL18779
Hanson JD, Kysar DA.
Taking behavioralism seriously: some evidence of market manipulation
Harv Law Rev. 1999 May;112:(7):1420-572.
http://www.ncbi.nlm.nih.gov/pubmed/10558427
HSL20418
Guidelines for evaluating papers on educational interventions
BMJ 1999 May;318:1265-1267
http://www.bmj.com/content/318/7193/1265
HSL2341
Wang TJ, Ausiello JC, Stafford RS.
Trends in antihypertensive drug advertising, 1985-1996.
Circulation 1999 Apr 20;99:(15):2055-7
http://circ.ahajournals.org/cgi/reprint/99/15/2055
HSL8099
Conlan MF.
Hot issues
Drug Topics 1999 Apr 19;143:80-82, 84, 87, 89
HSL8124
APhA sets policy on telepharmacy, DTC ads, unions
American Journal of Health System Pharmacy 1999 Apr 15;56:706-707
HSL6895
Working Group on Women and Health Protection
To do no harm: DTC advertising of prescription drugs
1999 Apr 12
www.hc-sc.gc.ca/hpb-dgps/therapeut/htmleng/consult_dtca.html
HSL2010
Schonhofer PS
Dipyrone (Metamizol): Restored to good repute?
Internistische Praxis 1999 Apr 0939:184-185
http://www.essentialdrugs.org/edrug/archive/199904/msg00014.php
HSL3689
Health Products and Food Branch, Health Canada.
Direct-to-consumer advertising of prescription drugs. [discussion document].
: Health Products and Food Branch, Health Canada. 1999 Apr 6
!www.hc-sc.gc.ca/hpfb-dgpsa/oria-bari/99-04-14_3_e.html.
HSL6894
Therapeutic Products Programme
Discussion document: direct-to-consumer advertising of prescription drugs
1999 Apr 6
www.hc-sc.gc.ca/hpb-dgps/therapeut/htmleng/consult_dtca.html
HSL20315
Hutchinson JM, Foley RN
Method of physician remuneration and rates of antibiotic prescription
CMAJ 1999 Apr 6;160:(7):1013–1017
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1230193/
HSL6889
Leach B.
Marketing forces
The Health Exchange 1999 Apr8-9
HSL6892
Pharmaceutical Manufacturers Association of Canada
Advertising of prescription medicines to Canadian consumers: PMAC’s position
Ottawa: Pharmaceutical Manufacturers Association of Canada 1999 Apr
www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/consult/wkshd2ca.zip www.canadapharma.org/special-report/adv-position/Advertising-DTC.html
HSL6893
Hayes L, Smith D.
Drug industry sponsorship: at what price?
HAI News 1999 Apr;(106):1-2, 15-16
HSL7974
Nolan A.
Issues & priorities for the pharmaceutical industry in Ireland
Irish Pharmacy Journal 1999 Apr;77:112-114
HSL8097
Buckley B.
Prescriptions grow 7% to 2.4 billion; sales increase 16% to $94 billion
Pharmacy Times 1999 Apr;65:16-18, 21-22
HSL18022
Mangione-Smith R, McGlynn EA, Elliott MN, Krogstad P, Brook RH.
The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior.
Pediatrics 1999 Apr;103:(4):
http://pediatrics.aappublications.org/cgi/content/full/103/4/711
HSL19393
Rizzo JA
Advertising and competition in the ethical pharmaceutical industry: the case of antihypertensive drugs
J Law Econ 1999 Apr;42:(1):89–116
http://ideas.repec.org/a/ucp/jlawec/v42y1999i1p89-116.html
HSL2011
Ragg M.
Capsule or pill, don't swallow it whole
Weekend Australian 1999 Mar 27
HSL20132
Rankin P
Offensive to GPs
Australian Doctor 1999 Mar 1926
HSL18021
Murphy JE.
Generic substitution and optimal patient care.
Arch Intern Med 1999 Mar 8;159:(5):429-33
http://archinte.ama-assn.org/cgi/content/full/159/5/429
HSL6875
Nathan DG, Weatherall DJ.
Academia and industry: lessons from the unfortunate events in Toronto.
Lancet 1999 Mar 6;353:(9155):771-2
http://linkinghub.elsevier.com/retrieve/pii/S0140673699000720
HSL20147
Sweet M
Getting to the consumer direct
Australian Doctor 1999 Mar 529
HSL1824
Razack S, Arbour L, Hutcheon R.
Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
Ann R Coll Physicians Surg Can 1999 Mar;32:(2):93-6
HSL6890
Law J.
Who will be the new voice of patients?
Scrip Magazine 1999 Mar30-33
www.pjbpubs.co.uk/scrip/scrhome.html
HSL6891
Memoirs of methods used to sell drugs
MaLAM International News 1999 Mar-Apr;17:(3-4):1-6
HSL7968
Kravetz S.
Pharmacy profession unites to endorse collaborative drug therapy management
Pharmacy Practice News 1999 Mar;26:10, 18
HSL7969
Wilcock M.
Take the heat out of prescribing
Pharmacy in Practice 1999 Mar;9:86-87
HSL7973
Bloom MZ.
Direct-to-consumer advertising provides challenge to managed care
Journal-of-Managed-Care-Pharmacy 1999 Mar-Apr;5:101-103, 106
HSL8123
Wechsler J.
Taking steps toward harmonization with Europe and Japan
Pharmaceutical Technology 1999 Mar;23:16, 18, 20-22, 24, 26, 28, 30
HSL8139
Consumers want details about prescription drugs; many use alternative medicines
American Journal of Health System Pharmacy 1999 Feb 15;56:307
HSL238
Wahlbeck K, Adams C.
Beyond conflict of interest: Sponsored drug trials show more-favourable outcomes.
BMJ 1999 Feb 13;318:(7181):465
HSL20520
Cresswell A
Plan for GPs to share prescription savings
Australian Doctor 1999 Feb 122
HSL239
Shuchman M.
Independent review adds to controversy at Sick Kids.
CMAJ 1999 Feb 9;160:(3):386-8
http://www.cmaj.ca/cgi/reprint/160/3/386
HSL6872
Mandelkern M.
Manufacturer support and outcome.
J Clin Psychiatry 1999 Feb;60:(2):122-3
HSL6888
Advertising of antibacterials
Health Skepticism 1999 Feb;2:(2):1-5
HSL8094
Troy T.
Clinical independence meets demands of government, health care users
Managed Healthcare 1999 Feb;9:30
HSL8096
Zoeller J.
Top 200 drugs: aggressive detailing and direct-to-consumer advertising are landing new products in the top 200 rankings much sooner
American Druggist 1999 Feb;216:41-44, 46, 48
HSL8113
West D.
United they stand: patient care providers and DTC campaigns shake on it
Pharmaceutical Executive 1999 Feb;2:6-8
HSL2101
Greenhalgh T.
Narrative based medicine: narrative based medicine in an evidence based world.
BMJ 1999 Jan 30;318:(7179):323-5
http://bmj.bmjjournals.com/cgi/content/full/318/7179/323
HSL6858
Hollon MF.
Direct-to-consumer marketing of prescription drugs: creating consumer demand.
JAMA 1999 Jan 27;281:(4):382-4
http://jama.ama-assn.org/cgi/content/full/281/4/382
HSL8142
Holmer AF.
Direct-to-consumer prescription drug advertising builds bridges between patients and physicians.
JAMA 1999 Jan 27;281:(4):380-2
http://jama.ama-assn.org/cgi/content/full/281/4/380
HSL8151
Landis NT.
Requirements for FDA-approved patient information spelled out in final rule
American Journal of Health System Pharmacy 1999 Jan 15;56:107-108
HSL8153
Landis NT.
Community pharmacy pricing suit dismissed
American Journal of Health System Pharmacy 1999 Jan 15;56:113
HSL2008
Zuger A.
Fever Pitch: Getting Doctors To Prescribe Is Big Business
New York Times 1999 Jan 11
HSL4751
Ravindran GD.
The physician and the pharmaceutical industry: both must keep the patient's interests at heart.
Issues Med Ethics 1999 Jan-Mar;7:(1):21-2
HSL6886
Advertising of CCBs for hypertension
Health Skepticism 1999 Jan;2:(1):3-4
HSL6887
Lexchin J.
Re: the promotion of Zaditen (ketotifen)
1999 Jan;
HSL8112
Gilderman A, Salas JC, Khoury-Chamoun L.
The effectiveness of an antibiotic use program.
Manag Care Interface 1999 Jan;12:(1):73-6
HSL8118
Wechsler J.
Policy issues for 1999
Pharmaceutical Executive 1999 Jan;19:20, 22, 26
HSL8126
Wechsler J.
Prices, patients, privacy top 1999 agenda
Pharmaceutical Technology 1999 Jan;23:14, 16-18, 20, 22, 24, 27
HSL1896
Gaedeke RM, Tootelian DH, Sanders EE.
Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
Health Mark Q 1999;17:(1):23-31
HSL2045
Heuer RJ.
. Psychology of Intelligence Analysis : Center for the Study of Intelligence, US Central Intelligence Agency 1999
http://www.cia.gov/csi/books/19104/index.html
HSL2315
Dolovich L, Levine M, Tarajos R, Duku E.
Promoting optimal antibiotic therapy for otitis media using commercially sponsored evidence-based detailing: A prospective controlled trial.
Drug Information Journal 1999;33:(4):1067-1077
http://www.findarticles.com/p/articles/mi_qa3899/is_199910/ai_n8852536#continue
HSL2327
Jones M, Greenfield S, Bradley C
A survey of the advertising of nine new drugs in the general practice literature.
Journal of Clinical Pharmacy and Therapeutics 1999;24:451-460
http://www.blackwell-synergy.com/doi/full/10.1046/j.1365-2710.1999.00255.x
Page 167 of 206 pages ‹ First < 165 166 167 168 169 > Last ›
